Combined Therapy of Low-Dose Angiotensin Receptor-Neprilysin Inhibitor and Sodium-Glucose Cotransporter-2 Inhibitor Prevents Doxorubicin-Induced Cardiac Dysfunction in Rodent Model with Minimal Adverse Effects

• 主要な著者: Donghyun Kim (著者), Gyuho Jang (著者), Jaetaek Hwang (著者), Xiaofan Wei (著者), Hyunsoo Kim (著者), Jinbae Son (著者), Sang-Jae Rhee (著者), Kyeong-Ho Yun (著者), Seok-Kyu Oh (著者), Chang-Myung Oh (著者), Raekil Park (著者)
• フォーマット: 図書
• 出版事項: MDPI AG, 2022-11-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Although cancer-therapy-related cardiac dysfunction (CTRCD) is a critical issue in clinical practice, there is a glaring lack of evidence regarding cardiotoxicity management. To determine an effective and suitable dosage of treatment using angiotensin receptor-neprilysin inhibitors (ARNI) with sodiu...